Entries tagged with “pharmaceutical-industry”

Articles

4 articles found for pharmaceutical-industry:

• Will Indian Generics Makers Target Niche Pharma Markets in the US?

  With growing interest in low-cost healthcare options, the US pharma market could be a more lucrative opportunity than their domestic markets for Indian generic drug makers.

• Pharma Deal-Making: In the Pink Of Health

  Deal-making in the global pharmaceuticals sector is booming, with no signs of slowing down.

• Edible Vaccines – A Research Area Waiting to Explode

  Ease of administration and patient compliant due to oral delivery

• Oral Insulin

  Diabetes is a type of metabolic disorder caused by an insulin imbalance in the body either due to insufficient production of insulin by the pancreas or due to body cells not responding to the insulin that is produced.

Blogs

6 blog posts found for pharmaceutical-industry:

• IoT Could Make a Difference in Pharmaceutical Manufacturing and Supply Chains

  The digitization of data and processes across the value chain coupled with the Internet of Things (IoT) could transform the pharmaceutical industry. 

• Pharmaceuticals – An Industry at Crossroads

  With patent cliffs, competition from generics to contend with, and mounting pressure from healthcare players, insurance companies and governments to provide vital products at affordable costs — the pharmaceutical industry may be in for some tough times ahead.

• Edible Smart Tags Could Beat Drug Counterfeiting

• 3D Printed Drugs: A Gateway To Customized Medicine

• Does Section 3(d) Make India Bad for Business?

  Introduced as an amendment to the Indian Patents Act in 2005, paragraph 3d has been a hot topic of debate ever since the famous Novartis (Gleevec) case of 2005. This section has long been criticized by international pharmaceutical companies as a bane, viewing it as a hurdle for the industry’s growth as it made India's patent environment unsuitable for doing business.
  
  Does it really though?

• The Healthcare Industry Could Have a Lot Riding on IoT

  Although just a small sub-set of IoT’s potential applications, its ability to revolutionize the mundane in healthcare and medicine is spurring some interesting developments.

Infographics

4 infographics found for pharmaceutical-industry:

• Nanoparticle-based Products Under Clinical Trials

  Since their advent in the late 1960s, several nanoparticle-based drugs are being clinically used in innovative therapeutic approaches with notable success.

• Commercially Available Nanoparticles for Cancer Treatment

  Since their advent in the late 1960s, several nanoparticle-based drugs are being clinically used in innovative therapeutic approaches with notable success.

• Global Refrigerated Transport Market

  A growing demand for frozen foods as well as better business models will bolster growth for the global refrigerated transport market.

• Staying Alive: What the world is spending on medicines | Infographic

  Global spending on medicines is on the rise and expected to rise to USD1,175 - USD1,205 billion by 2016; a CAGR of 4.2% to 4.7% as compared to 2011. This infographic on medicines / pharmaceuticals drugs gives a lowdown on how the world is spending on treatments.

Special Reports

3 special reports found for pharmaceutical-industry:

• Nanoparticle Drug Delivery Systems For Cancer Treatment

  Nanotechnology is a rapidly evolving domain solving various issues associated with conventional drug therapeutics, including poor water solubility

• Therapeutic Vaccines for Alzheimer’s — Are We Close Enough?

  Alzheimer's Disease (AD), one of the most common causes of dementia, accounts for nearly 70% of documented cases of Dementia across the world.

  The pharmaceutical industry is exploring all available options to develop a successful therapy, and the global market for Alzheimer’s treatment is expected to grow at a CAGR of 10.5%, from $4.9 billion in 2013 to $13.3 billion by 2023.

  This report covers current research into therapeutic vaccines for Alzheimer’s Disease (AD), with topics that include market drivers, challenges associated with developing safe next-gen therapeutics, vaccines and therapies currently under development, as well as the technology and commercial ecosystem for AD therapy.

• Pharma Patent Monetization: New Approaches, New Synergies

  Patents are the undisputable kingmakers in the life sciences industry.